Cytarabine- and daunorubicin-containing product in parenteral dose form 1290602003
SNOMED CT code
SNOMED code | 1290602003 |
---|---|
name | Cytarabine- and daunorubicin-containing product in parenteral dose form |
status | active |
date introduced | 2023-10-01 |
fully specified name(s) | Product containing cytarabine and daunorubicin in parenteral dose form (medicinal product form) |
synonyms | Cytarabine- and daunorubicin-containing product in parenteral dose form |
attributes - group0 | |
Has manufactured dose form | Parenteral dose form 385287007 |
Plays role | Antineoplastic therapeutic role 773879000 |
attributes - group1 | |
Has active ingredient | Daunorubicin 372715008 |
attributes - group2 | |
Has active ingredient | Cytarabine 387511003 |
parents |
|
children | Cytarabine and daunorubicin only product in parenteral dose form 1290604002 |
hierarchies | a selection of possible paths SNOMED CT Concept 138875005Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Medicinal product categorized by structure 763760008 Anthracycline antineoplastic agent 108787006 Daunorubicin-containing product 35300007 Cytarabine- and daunorubicin-containing product 1290603008 Cytarabine- and daunorubicin-containing product in parenteral dose form 1290602003 SNOMED CT Concept 138875005 Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Product manufactured as parenteral dose form 440132002 Cytarabine-containing product in parenteral dose form 714225009 Cytarabine- and daunorubicin-containing product in parenteral dose form 1290602003 SNOMED CT Concept 138875005 Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Product manufactured as parenteral dose form 440132002 Daunorubicin-containing product in parenteral dose form 714237006 Cytarabine- and daunorubicin-containing product in parenteral dose form 1290602003 |
ancestors | sorted most to least specific
|
cpt crosswalks |
Thank you for choosing Find-A-Code, please Sign In to remove ads.